MATINAS BIOPHARMA HOLDINGS, INC. Employee-related Liabilities
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Employee-related Liabilities of $633.00 thousand as of 2018-12-31, per its 10-K filed 2019-04-01.
Discontinued › Balance Sheet › Liabilities › Accrued Liabilities
us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent · last filed 2019-04-01
- 2018-12-31: Employee-related Liabilities $633.00K.
- 2018-09-30: Employee-related Liabilities $461.00K.
- 2018-06-30: Employee-related Liabilities $607.00K.
- 2018-03-31: Employee-related Liabilities $253.00K.
| Period end | Employee-related Liabilities |
|---|---|
| 2018-12-31 | $633.00K 10-K · filed 2019-04-01 |
| 2018-09-30 | $461.00K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $607.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $253.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $721.00K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |